SCHEMBL26763376

SCHEMBL26763376

c1ccc(-c2cccc(-c3nc(-c4ccccc4)nc(-c4ccc5c(c4)sc4cc(-c6cc(-c7ccccc7)c7sc8ccccc8c7c6)ccc45)n3)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 7/20 0.39
ALOX5 P09917 1/20 0.39
TNKS O95271 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36
PIM3 Q86V86 2/20 0.36
MAPT P10636 2/20 0.36
LIMK2 P53671 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PIK3CA P42336 1/20 0.34
PI4KA P42356 1/20 0.34
PI4KB Q9UBF8 1/20 0.34
F9 P00740 1/20 0.34
PIM1 P11309 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HSD17B1 P14061 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26763389 0.98 LIMK1 (0.38) LIMK1ALOX5TNKSTNKS2PIM3
SCHEMBL26763377 0.98 ALOX5 (0.41) LIMK1ALOX5TNKSTNKS2PIM3
SCHEMBL26227961 0.98 ALOX5 (0.41) LIMK1ALOX5TNKSTNKS2PIM3
SCHEMBL26763710 0.98 ALOX5 (0.41) LIMK1ALOX5TNKSTNKS2PIM3
SCHEMBL26245605 0.98 LIMK1 (0.41) LIMK1ALOX5TNKSTNKS2PIM3
SCHEMBL23230603 0.96 LIMK1 (0.39) LIMK1ALOX5TNKSTNKS2PIM3
SCHEMBL26217318 0.96 LIMK1 (0.39) LIMK1ALOX5TNKSTNKS2PIM3
SCHEMBL26224250 0.95 ALOX5 (0.40) LIMK1ALOX5TNKSTNKS2PIM3
SCHEMBL26763716 0.95 ALOX5 (0.40) LIMK1ALOX5TNKSTNKS2PIM3
SCHEMBL26763164 0.95 LIMK1 (0.39) LIMK1ALOX5TNKSTNKS2PIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357209-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-11-09 US disclosed
US-20230357209-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357209-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE CYP1A1, CYP1B1, ODC1 LIMK1 270/4885ALOX5 309/4885TNKS 2676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.